|Articles|April 20, 2018

Lung Cancer Drug Approval Tops SPT Week in Review

Top news of the week from Specialty Pharmacy Times.

5. New Opioid Prescribing Guidance Targets Inpatient Acute Pain Management

Until now, there has been little guidance on the safe prescribing of opioids in the inpatient, non-operative setting. Read more.

4. FDA Approves First-Line Treatment Combo for Advanced Renal Cell Carcinoma

Opdivo and Yervoy combination is the first and only treatment to show significantly superior survival compared with sunitinib in intermediate- and poor-risk advanced RCC. Read more.

3. Inlyta Fails to Demonstrate Efficacy in Patients at High Risk of Recurrent Renal Cell Carcinoma

In its phase 3 trial, Pfizer’s axitinib (Inlyta) did not achieve disease-free survival in patients at high risk of recurrent renal cell carcinoma after nephrectomy. Read more.

2. Merck Announces Positive Phase 3 Results for Keytruda as Lung Cancer Therapy

Pembrolizumab (Keytruda) met its primary endpoint in the pivotal phase 3 KEYNOTE-042 trial. Read more.

1. FDA Approves Osimertinib for Treatment of Non-Small Cell Lung Cancer

Osimertinib surpassed standard of care with a median progression-free survival of 18.9 months in clinical trials. Read more.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

In-Person + Virtual Event

ASCP 2025 Satellite Symposia

October 24-25, 2025

Satellite Symposia

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

October 25, 2025 | 11:00 AM - 12:00 PM ET

Webinar Registration

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

October 28, 2025 | 12:00 PM & 7:00 PM EDT

Webinar Registration

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

October 28, 2025 | 1:00 PM & 6:00 PM ET

Satellite Symposia

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

October 29, 2025 | 12:00 PM

In-Person + Virtual Event

AMCP Nexus 2025

October 27-29, 2025

Lung Cancer Drug Approval Tops SPT Week in Review

Newsletter

Related Content

Disparities in Continuous Glucose Monitor Prescriptions by Language Preference Among Adults With Type 2 Diabetes

FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms

FDA Approves Revumenib for NPM1-Mutated, Relapsed/Refractory AML

New Data Show Elinzanetant Is a Safe, Well-Tolerated Non-Hormonal Therapy for Menopausal Vasomotor Symptoms

High Non-HDL-C/HDL-C Ratio in Adults With Obesity Increases Depression Risk

Latest CME

ASCP 2025 Satellite Symposia

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

AMCP Nexus 2025

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management (Pharmacy Technician Credit)

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine Uptake and Optimally Utilize Available Vaccines

The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non‒Small Cell Lung Cancer

Asembia Specialty Pharmacy Day of Education 2025

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Balancing the Burden of Moderate to Severe Atopic Dermatitis in Pediatric Patients: Navigating the Use of Targeted Biologic Therapies and Caregiver Challenges

Addressing Gaps in Care for Hyperkalemia With Novel Oral Potassium Binding Agents

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Risk Populations and Vaccine Uptake

Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Directions in Oncology Pharmacy® 2025: Northeast

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

How Artificial Intelligence Is Transforming Cancer Care: Essential Insights for Oncology Pharmacists

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Exploring the Role of Glucagon Like Peptide Receptor 1 Agonists (GLP-1RA) in the Treatment of Obesity (Pharmacist Credit)

Enhancing Safety in Cancer Care: Expert Guidance on Toxicity Management of HER2, TROP2, and HER3-Targeted Antibody-Drug Conjugates

Enhancing Endometrial Cancer Management: Highlights of Molecular Insights, Treatment Approaches, and Toxicity Management

A Pharmacist's Guide to the Safe and Effective Management of BTK and BCL-2 inhibitors in Chronic Lymphocytic Leukemia

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians (Pharmacy Technician Credit)

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians

ASHP Midyear 2025

Overview and Burden of Migraine

Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes

Emerging Biologic Therapy for the Management of COPD: Integrated Approaches to Optimized Care

The Impact and Role of Pharmacists in the Management of Specialty Therapies

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

Exploring Advances in the Management of DOAC-Associated Bleeding With Reversal Agents: Role of the Health-System Pharmacists

Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Navigating Diabetes: A Guide to Effective Oral Treatments

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

The Role of the Pharmacist in the Management of Hyperlipidemia

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis (Pharmacy Technician Credit)

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Beyond the Spots: Management of Measles

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma

Tracking a Moving Target in HR+ Metastatic Breast Cancer: Innovative Oral Therapies and Evolving Strategies

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Advancing Care in HER2-Negative Early Breast Cancer: Essential Insights and Best Practices for Oncology Pharmacists

Navigating the World of Insulin: An Update on Types, Uses, and Considerations

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Aiming for Accuracy in Non-Small Cell Lung Cancer Treatment: Precision Strategies for Oncology Pharmacists

Advancing Chronic Lymphocytic Leukemia Treatment in the Community: Practical Updates and Clinical Pearls for Oncology Pharmacists

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Shaping the Future of Renal Cell Carcinoma: A Case-Based Exploration of Emerging Treatment and Improved Patient Outcomes

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches